Paratek Pharmaceuticals Inc.

06/16/2021 | Press release | Distributed by Public on 06/16/2021 05:33

Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with[...]